This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Cómo innovar en el modelo de negocio para salir de la crisis
IESE InsightArticle 74920Entrepreneurship, Innovation and Change, StrategyCon la COVID-19, no hay normalidad que valga. Ahora bien, las restricciones impuestas para proteger la salud pública no tienen por qué limitar la imaginación de los líderes empresariales. Es un momento propicio para la innovación en el modelo de negocio, es decir, para cambiar el modo en que se crea valor. Christoph Zott y Raphael Amit comparten ideas de su nuevo libro para líderes emprendedores.Starting at €8.20
-
Competir con inteligencia artificial
Larrañaga P.; Bielza C.Article 74919Information TechnologiesLos equipos deportivos están aprovechando cada vez más el poder de la inteligencia artificial para mejorar su rendimiento. Aquí hay cinco cosas que las empresas pueden aprender de ellos para lograr resultados ganadores.Starting at €8.20
-
Amir Dan Rubin: Success from the Beginning
Pfeffer, JCase SGSB-OB90-ECorporate Governance, StrategyIn November of 2010, the board of Stanford Hospital and Clinics announced that Amir Dan Rubin, at the time chief operating officer of the UCLA Hospital System, would become the next CEO at Stanford Hospital and Clinics. Although by 2010 Stanford hospital had largely recovered from a failed merger with the hospital of the University of California, San Francisco, and was financially stable, Rubin would lead an organization that still faced signifi...Starting at €8.20
-
PATH and the Safe Water Project: Making Safe Water Products More Affordable
Zenios S; Denend L; Elliott TCase SGSB-OIT109-EInformation Technologies, Service and Operations ManagementThis case provides an overview of the nonprofit organization PATH and its Safe Water Project—a five-year effort launched in late 2006 with $17 million in funding from the global development unit of the Bill and Melinda Gates Foundation. The purpose of the grant was to evaluate to what extent market-based approaches could help accelerate the widespread adoption and sustained use of household water treatment and safe storage products by low-income ...Starting at €8.20
-
Landlocked Homes: Catching a Falling Knife
Abbey, D; Mahowald, C; Lamont, MCase SGSB-RE137-EStrategyWhen Jacob Harold became head of the Hewlett Foundation’s Philanthropy Program, he began to see GuideStar as much more than just a website. GuideStar was the result of founder Arthur “Buzz” Schmidt’s vision of bringing transparency and accountability to the world of nonprofits. At its core, the organization compiled information that U.S. nonprofits submitted on their IRS filings into an easy to use database. It supplemented that information wi...Starting at €8.20
-
TTTech (C ): Hitting the Gas Pedal
Siegel RCase SGSB-SM185C-EStrategyTo be used in conjunction with the (A) and (B) cases, keeping the students current on the status of the firm.Starting at €8.20
-
Health Leads (A): Expansion Decisions for a Health Care Nonprofit
Sorensen J; Schifrin D; Hettrich KCase SGSB-SM192A-EStrategyThe (A) case presents a 2009 critical expansion decision for health care nonprofit Health Leads: whether to expand rapidly while it had momentum, strong advocates, very high demand for its services, and funder support for growth; or whether to postpone rapid expansion and continue working on its model and further prove the company’s value to hospitals and clinics. Founded by Rebecca Onie (2009 MacArthur “Genius Grant” Fellow), Health Leads addre...Starting at €8.20
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209A-EStrategyFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
Waste Management's Organic Growth Group
Burgelman, R; Siegel, R; Uribe, TCase SGSB-SM210-EStrategyIt was 2005 and David Steiner, CEO of Waste Management (WM), had just received a report from an internal advisory panel created some months before to assess the future of the waste management industry and propose how the company’s strategy should be adapted. The core of this report was the recommendation to create a special unit within the company, chartered with the central purpose of identifying ways to extract value from waste through new and ...Starting at €8.20